Clearmind Medicine Files 6-K with Conversion Agreement

Ticker: CMND · Form: 6-K · Filed: Apr 15, 2026

Sentiment: neutral

Topics: conversion-agreement, filing, pharmaceuticals

TL;DR

Clearmind Medicine filed a 6-K with a conversion agreement attached. Potential financial restructuring incoming.

AI Summary

Clearmind Medicine Inc. filed a Form 6-K on April 15, 2026, reporting a conversion agreement as an exhibit. The company, based in Vancouver, British Columbia, operates in the Pharmaceutical Preparations sector.

Why It Matters

This filing indicates a potential change in the company's financial structure or ownership through a conversion agreement, which could impact its future operations and investor relations.

Risk Assessment

Risk Level: medium — Filings of conversion agreements can signal financial restructuring or debt conversion, which may introduce uncertainty or changes in equity structure.

Key Players & Entities

FAQ

What is the primary purpose of the Form 6-K filing by Clearmind Medicine Inc. on April 15, 2026?

The Form 6-K filing on April 15, 2026, by Clearmind Medicine Inc. is to report a conversion agreement as an exhibit.

What is the CIK number for Clearmind Medicine Inc.?

The CIK number for Clearmind Medicine Inc. is 0001892500.

Where is Clearmind Medicine Inc. located?

Clearmind Medicine Inc. is located at 101-1220 West 6th Avenue, Vancouver, British Columbia Z4 V6H1A5.

What type of company is Clearmind Medicine Inc. classified as by the SIC code?

Clearmind Medicine Inc. is classified under SIC code 2834, which pertains to Pharmaceutical Preparations.

What is the accession number for this specific SEC filing?

The SEC accession number for this filing is 0001213900-26-043758.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 15, 2026 regarding Clearmind Medicine Inc. (CMND).

View full filing on EDGAR

View on Read The Filing